Health News Releases

  • Today May 19
January 11, 2018 19:25
Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine
Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development
January 11, 2018 17:30
Parrish Medical Center Awarded Patient Safety Movement’s First 5-Star Hospital Ranking
The Patient Safety Movement Foundation (PSMF) today awarded Florida-based Parrish Medical Center with the first-ever Patient Safety Five-Star Hospital ranking for implementing all 13 Actionable Patien
January 11, 2018 17:20
AHF Strongly Condemns Violence Against Rohingya in Rakhine State, Myanmar
AIDS Healthcare Foundation (AHF) strongly condemns violence against the Rohingya Muslims in Myanmar’s Rakhine State. As a global humanitarian organization, with operations in 39 countries, including M
January 09, 2018 17:15
Save Lives, Fish with President Carter and Patient Safety Movement Foundation
For the fourth year in a row, former President Jimmy Carter and First Lady Rosalynn Carter are supporting the Patient Safety Movement Foundation (PSMF) and demonstrating their commitment to ZERO Preve
January 09, 2018 11:35
Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)
Synapse Biomedical (www.synapsebiomedical.com), an innovator in neurostimulation and manufacturer of the NeuRx Diaphragm Pacing System®, announced today, the CE Mark approval for the TransAeris™ Syste
SELVAS AI will exhibit “Selvy Checkup,” the world's first AI disease prediction service, at CES 201
January 09, 2018 08:00
SELVAS AI to be in spotlight at CES 2018 for ‘Selvy Checkup’, World’s First AI Disease Prediction Service
SELVAS AI, an artificial intelligence company, will participate in CES (Consumer Electronics Show) 2018, the world’s largest consumer technology event in Las Vegas, Nevada, USA, from January 9 to 12.
GE, Roche Enter Partnership to develop an industry-first digital platform, using advanced analytics
January 08, 2018 16:55
GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The partnership
January 08, 2018 10:20
ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today the receipt of a sole source contract from the Defense Logisti
January 04, 2018 13:10
HeartSciences, a Fierce Innovation Award Finalist, Will Present at BioTech Showcase Events in San Francisco on January 9 and 10, 2018
HeartSciences, a medical device company recently selected as a finalist for the Fierce Innovation Awards in the Digital Health Solution category, will be presenting in San Francisco at the BioTech Sho
January 04, 2018 09:15
Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€
Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million. The additional funds wil
January 03, 2018 10:15
Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
Masimo (NASDAQ: MASI) announced today the CE marking and release of RD rainbow Lite SET™ sensors, which enable the monitoring of Masimo Oxygen Reserve Index™ (ORi™) and RPVi™, an improved PVi® that al
Denis DELVAL, CEO of LFB S.A.
December 22, 2017 08:57
Denis DELVAL is Appointed CEO of LFB SA
On December 20th, a decree from the President of France was published in Le Journal Officiel* appointing Denis DELVAL CEO of LFB S.A. This decree follows the General Meeting of LFB SA and the meeting
December 21, 2017 11:15
LMD Welcomes ‘Smartphone-as-Medical-Instrument’ Trend and Highlights Need for Clinical Accuracy
Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has welcomed news that other companies are enterin
December 12, 2017 14:30
Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ECHELON-1 clinical trial evaluating ADCETRIS (brentuximab vedotin)
December 12, 2017 09:30
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against c
December 11, 2017 09:30
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today presented results from the Phase Ib/II ACE-CL-003 clinical trial (Abstract #432) and updated results
December 11, 2017 09:20
Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
Celgene Corporation (NASDAQ: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-cell
December 11, 2017 09:10
AstraZeneca’s Calquence (acalabrutinib) Demonstrates Activity in Relapsed or Refractory Mantle Cell Lymphoma Trial
AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today presented results from the open-label, single-arm Phase II ACE-LY-004 clinical trial, which served a
December 08, 2017 17:45
Bertin and Zymo Research Announce New Collaboration
Zymo Research Corp. and Bertin announce a collaboration that ensures the sample lysis step in the microbiome workflow is complete and unbiased. An application note is available describing the material
December 06, 2017 09:45
PMC Group International Announces Acquisition of Pharma Company in France
PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of Isochem SAS of France. T
December 04, 2017 14:05
Herbalife Nutrition Appoints Renowned Thai Sports Medicine Expert to Its Nutrition Advisory Board
In helping the world live happier and healthier, premier global nutrition company Herbalife (NYSE:HLF), announced today the appointment of Dr. Korakod Panich, M.D., a sports medicine expert in Thailan
December 04, 2017 11:20
Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet™ Across All Hospital Care Areas
Masimo (NASDAQ: MASI) announced today that Artemis Hospital, one of the leading multi-specialty hospitals in the Delhi-NCR region of India, is adopting Masimo Patient SafetyNet™*, a supplemental remot
December 01, 2017 17:25
Takeda Appoints Toshio Fujimoto, MD, MBA, as General Manager of the Health Innovation Park in Shonan
Takeda Pharmaceutical Company Limited [TSE: 4502] announced today that Toshio Fujimoto, MD, MBA has been appointed General Manager of the Health Innovation Park in Shonan. The appointment is effective
November 29, 2017 08:20
Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a Phase
November 27, 2017 15:35
Ferring Receives Swiss Approval For Rekovelle®, The First Personalised Fertility Treatment Using an Approved Dosing Algorithm
Ferring Pharmaceuticals announced today that Swissmedic has approved Rekovelle® (follitropin delta) for use in controlled stimulation for induction of the development of multiple follicles in women un
25 per page50 per page75 per page100 per page